CIK 0001661059 · Non-accelerated filer<br>Smaller reporting company
NextCure, Inc.
Sign in to watch- Ticker
- NXTC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475231247
- Phone
- 240-399-4900
- Business address
- 2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 21209
- Open-market buys, last 90 days
- $77,590
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$77,590. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-23 | Houston John G Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2022-06-23 | Nicholson Garry A Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2022-06-23 | Webster Stephen W Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2022-06-23 | Khuong Chau Quang Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2022-06-23 | Jones Elaine V Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2022-06-23 | KABAKOFF DAVID S Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2022-01-31 | Liu Linda SVP, Research | Grant or award · Employee Stock Option (Right to Buy) | +65,600 | 65,600 | ||
| 2022-01-31 | Langermann Sol Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +117,400 | 117,400 | ||
| 2022-01-31 | Kundu Sourav Sr VP, Dev. & Mfg. | Grant or award · Employee Stock Option (Right to Buy) | +58,700 | 58,700 | ||
| 2022-01-31 | Richman Michael President & CEO | Grant or award · Employee Stock Option (Right to Buy) | +262,400 | 262,400 | ||
| 2022-01-31 | Mayer Timothy Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +131,200 | 131,200 | ||
| 2022-01-31 | Cobourn Steven P. Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +96,700 | 96,700 | ||
| 2022-01-31 | Myint Han Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +103,600 | 103,600 | ||
| 2021-10-01 | Feigal Ellen Director | Grant or award · Stock Option (Right to Buy) | +28,500 | 28,500 | ||
| 2021-10-01 | Feigal Ellen Director | Grant or award · Stock Option (Right to Buy) | +10,384 | 10,384 | ||
| 2021-10-01 | Borgman Anne Elizabeth Director | Grant or award · Stock Option (Right to Buy) | +28,500 | 28,500 | ||
| 2021-10-01 | Borgman Anne Elizabeth Director | Grant or award · Stock Option (Right to Buy) | +10,384 | 10,384 | ||
| 2021-07-15 | Kundu Sourav Sr VP, Dev. & Mfg. | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2021-06-24 | Houston John G Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2021-06-24 | Nicholson Garry A Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 |
Page 5 of 10 · 197 trades